Overview

A Study to Evaluate Drug-drug Interaction of ZX-7101A Tablets and Oseltamivir Phosphate Capsules in Healthy Adult Subjects

Status:
Recruiting

Trial end date:
2024-04-29

Target enrollment:

Participant gender:

Summary

The primary object of this study is evaluating the effect of multiple oral oseltamivir phosphate capsules on the pharmacokinetic profile of the active metabolite ZX-7101 after a single oral administration of ZX-7101A tablet in healthy Chinese adult subjects. The seongdary object is evaluating combined or uncombined multiple oral oseltamivir phosphate in healthy Chinese adult subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Nanjing Zenshine Pharmaceuticals

Treatments:

Oseltamivir